Advisory Boards

The CCF Advisory Boards consist of key opinion leaders, scientists, clinicians and healthcare providers who are active in the education, treatment, clinical and basic research of cholangiocarcinoma and are committed to furthering the CCF mission. Advisory Board members serve to guide the CCF with a diversity of perspectives, providing assistance and insight into the vision and mission of the CCF from a medical/scientific perspective. In addition, the Advisory Boards provide guidance on strategic medical and scientific direction for the Executive Board of Directors.

Medical Advisory

Chair, Ghassan K. Abou-Alfa, MD

Ghassan K. Abou-Alfa is an appointed physician at Memorial Sloan-Kettering Cancer Center and associate professor of the Weill Cornell Medical College in New York. Dr. Abou-Alfa specializes in the treatment of gastrointestinal malignancies with a special focus on cholangiocarcinoma, biliary cancers, and hepatocellular carcinoma. Dr. Abou-Alfa received his medical degree from the American University of Beirut, Lebanon, and completed his post-doctoral training at Yale University School of Medicine. His research is dedicated to finding novel therapies and improving the effectiveness current therapies for cholangiocarcinoma, biliary cancers and hepatocellular carcinoma, while continuing to understand the basic mechanisms of the diseases and its therapy. Dr Abou-Alfa has many publications in the field. He led on many occasions, international teams of investigators. Dr. Abou-Alfa serves as the chair of the National Cancer Institute (NCI) Task Force for...

Vice Chair, Juan Valle, MB ChB MSc FRCP

Professor Juan Valle is a Professor of Medical Oncology in the University of Manchester (Institute of Cancer Studies); part of the Manchester Academic Health Sciences Centre. He is based in the Department of Medical Oncology at The Christie NHS Foundation Trust within the Gastrointestinal Disease Group and treats cancers of the pancreas, liver and biliary tract, neuroendocrine tumours and colorectal cancer. He is Head of Service for The Christie Neuroendocrine Team which has, under professor Valle’s leadership, been recognised as a Centre of Excellence for the treatment of patients with neuroendocrine tumours (NETs) by ENETS (the European Neuroendocrine Tumour Society). Prof. Valle is a member of the UK National Cancer Research Network (NCRN) Upper Gastrointestinal Clinical Studies Group and member of the hepatobiliary and...

Clinical Science
Advisory Board

Chair, Alan P. Venook, MD

Dr. Alan Venook is the Madden Family Distinguished Professor of Medical Oncology and Translational Research at the University of California, San Francisco (UCSF) and is the Shorenstein Associate Director for Program Development at the Helen Diller Family Comprehensive Cancer Center at UCSF.  Dr. Venook received a BA in Biological Sciences from Rutgers College in 1976, his MD Degree in 1980 from UCSF, completed his internship at UCSF in 1981and then spent two years in the Public Health Service.  He completed residency in Internal Medicine at the University of California, Davis and then returned to UCSF as a Hematology / Oncology Fellow in 1985, joining the faculty in 1988. Dr. Venook’s initial clinical research projects involved multidisciplinary collaborations to treat tumors via the hepatic artery.  In 1990 he described the UCSF experience with chemoembolization for patients...

Vice Chair, Milind Javle, MD

Dr. Javle received his medical degree at Grant Medical College, University of Bombay, in Bombay, India. He then pursued postgraduate training in Internal Medicine at the State University of New York (SUNY) in Buffalo, NY, followed by a clinical fellowship in medical oncology at Roswell Park Cancer Institute in Buffalo, NY. He is a Professor of Gastrointestinal (GI) Medical Oncology at the MD Anderson Cancer Center in Houston, TX. He has served in the past as Assistant Professor of Medical Oncology at Roswell Park Cancer Institute and has been a faculty member at MD Anderson Cancer Center since 2007, in the GI Medical Oncology Division, with research interests in pancreatic and biliary cancers. His research interests include identification of molecular subtypes of pancreatic and...

Basic Science
Advisory Board

Chair, Nabeel Bardeesy, PhD

Dr. Bardeesy is an Associate Professor of Medicine at Harvard Medical School and the Massachusetts General Hospital Cancer Center. He is the recipient of the Gallagher Endowed Chair in Gastrointestinal Cancer Research. His lab focuses on the interface of metabolism and epigenetic reprogramming in GI cancers and in the development of genetically engineered mouse models of human cancer. Dr. Bardeesy received both his BS and PhD in Biochemistry from McGill University in Canada, followed by a Postdoctoral Fellowship in Medical Oncology at the Dana-Farber Cancer Institute at Harvard Medical...

Vice Chair, Ben Stanger, MD PhD

Dr. Stanger is an Associate Professor of Medicine and Cell and Developmental Biology at the University of Pennsylvania, where he is a practicing gastroenterologist. His laboratory studies the intersection between development of the GI tract and gastrointestinal cancers, with an emphasis on the pancreas, liver, and biliary tract. Dr. Stanger received his SB degree from MIT and his MD and PhD in Genetics from Harvard Medical School. His did a residency in Internal Medicine UCSF and a clinical fellowship in Gastroenterology at Massachusetts General Hospital, followed by a postdoctoral research fellowship at Harvard...

General Science
Advisory Board